A Study to Investigate the Efficacy and Safety of ONO-4578 in Combination With Nivolumab and Chemotherapy in Chemotherapy-naïve Participants With HER2-negative Unresectable Advanced or Recurrent Gastric Cancer (Including Esophagogastric Junction Cancer)
Clinical trial NCT06256328 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06256328
- Sponsor
- Ono Pharmaceutical Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-10
- Primary completion
- 2025-10-09
- Enrollment
- 226
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.